SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs admitted affair and the boards investigation into whether he was targeted by a suspected Chinese intelligence asset are dominating discussion. Traders are split between fearing national-security, governance and leadership fallout and viewing the controversy as an overblown distraction from Nvidias AI business.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,109,709. The last known price of Bitcoin is 75,069.21675003 USD and is down -0.79 over the last 24 hours. It is currently trading on 12776 active market(s) with $16,756,193,523.71 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins sharp selloff and tests of key moving-average support are driving attention, with traders citing heavy selling and liquidations while debating whether the breakdown signals more downside. Bearish calls for a deeper decline are widespread, though some traders view the pullback as a bear trap or buying opportunity.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Nvidia CEO Jensen Huangs admission of an affair and the boards investigation have fueled concern about governance and possible security implications, with traders debating whether the episode could weigh on the broader AI and semiconductor trade. Some see the QQQ pressure as overblown and favor buying the dip, while others point to the wider tech selloff and warn of further volatility.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

SMCI is rebounding after a sharp selloff despite strong quarterly results and higher full-year revenue guidance. Bulls point to its growth and low valuation, while skeptics remain concerned about thin margins, inventory and cash flow, and the durability of AI data-center demand.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

A sharp rebound in semiconductor shares after a severe selloff has traders debating whether SOXL is starting a recovery or merely staging a relief bounce. Community views remain divided, with concerns about AI data-center spending and Nvidia-related headlines weighed against dip-buying and confidence in longer-term chip demand.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Nvidia CEO Jensen Huangs acknowledged affair and the boards investigation, alongside unverified allegations of a link to a suspected Chinese intelligence asset, are fueling debate about spillover from AI and semiconductor weakness into the broader market. SPY traders are split between expecting more downside and viewing the indexs rebound and relative resilience as evidence the Nvidia story is not a lasting market driver; Iran headlines and upcoming inflation data are also cited as volatility risks.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Ciscos quarterly report is the main focus, with traders watching AI-networking demand, guidance and margins after a steep share-price pullback. Some are positioning for an oversold bounce, while skeptics question whether data-center orders will hold up and whether inventory growth or weaker traditional network refreshes could pressure results.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Traders are speculating that controversy surrounding Nvidia CEO Jensen Huang could shift investor interest toward AMD, while some warn that Nvidias troubles or broader AI-sector weakness could weigh on semiconductors. The discussion also balances AMDs data-center growth and sharp rebound after the chip selloff against doubts that the bounce will hold amid AI-spending and regulatory concerns.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.11892236 USD and is down -3.62 over the last 24 hours. It is currently trading on 1894 active market(s) with $1,884,610,999.15 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs steep decline amid a broader crypto-market selloff is driving talk of further downside and where support may emerge. Traders are split between calling the drop a buying opportunity and accumulating, versus selling or questioning XRPs utility and Ripples benefit to token holders.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

A broad S&P 500 pullback and heightened market volatility are driving attention, with traders pointing to tech-sector weakness, rising-rate and inflation concerns, and geopolitical uncertainty. The community is split between warnings of a deeper downturn and investors treating the decline as a buying opportunity or staying invested for the long term.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SLS $ABVX First Remission (CR1) Median Overall Survival Absent Transplant  
BAT/ SOC is Onureg / ORAL AZ - MOS is 24.7 MONTHS*  
  
-- Adding Venetoclax to Oral AZ Failed to Increase MOS in 5 Large Trials, including 2 Phase 3 Trials, conducted by $ABBV for AML Remission  
• VIALE-M Failed in First Remission Transplant Ineligible AML  
• VIALE-T Failed in Post Transplant Maintenance  
  
Dr. Kantarjian of MD ANDERSON, Published Data showing ADDING Venetoclax to Oral AZ for First Remission - MOS OF JUST 18.6 months.  
  
*GPS has proven effective in Preventing Relapse and Extending Survival in ALL Previous Trials INCLUDING In 2 Phase 2 Trials for AML REMISSION PATIENTS Ineligible for Transplant ---   
•• With a MOS &gt; 67.6 Months in FIRST REMISSION // 67.6 vs BAT 24.7  
• 21 Month MOS in Second Remission / Stat Sig, all MRD+ and Older who got less Gps immunotherapy - just 12 doses in Year 1 vs 15 Y1 doses and extended beyond in the REGAL P3. 
 
// 
 
//

Peggy Murphy

ming yu

bikechain

5,500% ROI this quarter

The Rager

YEHMINGZHU

charles2_01

Ulaughing

ilcail

Chessdoc

Francis Armonio

$SLS Does everyone remember when $ABVX was bumping around from $5 - $10 per share ? and then it T1 Trading Halted when Announced its P3 Trial Results ? 
and then Opened UP +600% at $60 Per Share? 
from $10 to$60 in a heartbeat... 
and it Kept Climbing 
to a high of $147 Per Share  
 
From $5 to $147 all Based on P3 Trial Results 
 
Something very similar is about to Happen HERE&gt;

StockTwits Web

SELLAS Life Sciences Group Inc

Abivax - ADR

$SLS  
Gps MOS &gt; 67.6 Months  
Current BAT MOS =24.7 Months 
 
in the same exact 
setting.  
 
its not complicated.

$SLS today 
https://x.com/dr_amerzeidan/status/2119544588566487481?a=p9oKuOqCksHbAu_LMQ4&amp;s=46

$SLS $MRNA Aza + Ven / BAT for SLS P3 control patients is Toxic. 
 
it failed 5 to increase OS in 5 Recent Clinical trials - due to toxicity. 
 
23% of the VIALE-A patients died from taking Aza+Ven. 
Viale-T Failed 
Viale-M Failed 
 
//

$SLS Gps Phase 3 MOS for Second Remission patients will come in &gt; 34 months - longer than the MOS for SOC /BAT in First Remission - without the toxicity.

Abbvie Inc

 First Remission (CR1) Median Overall Survival Absent Transplant  
BAT/ SOC is Onureg / ORAL AZ - MOS is 24.7 MONTHS*  
  
-- Adding Venetoclax to Oral AZ Failed to Increase MOS in 5 Large Trials, including 2 Phase 3 Trials, conducted by 

 for AML Remission  
• VIALE-M Failed in First Remission Transplant Ineligible AML  
• VIALE-T Failed in Post Transplant Maintenance  
  
Dr. Kantarjian of MD ANDERSON, Published Data showing ADDING Venetoclax to Oral AZ for First Remission - MOS OF JUST 18.6 months.  
  
*GPS has proven effective in Preventing Relapse and Extending Survival in ALL Previous Trials INCLUDING In 2 Phase 2 Trials for AML REMISSION PATIENTS Ineligible for Transplant ---   
•• With a MOS > 67.6 Months in FIRST REMISSION // 67.6 vs BAT 24.7  
• 21 Month MOS in Second Remission / Stat Sig, all MRD+ and Older who got less Gps immunotherapy - just 12 doses in Year 1 vs 15 Y1 doses and extended beyond in the REGAL P3. 
 
// 
 
//